Medlive Technology Co., Ltd. (2192.HK)
HKD 9.77
(-1.31%)
HKD 9.77
(-1.31%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 248.61 Million CNY | 45.12% |
| 2022 | 171.31 Million CNY | 19.49% |
| 2021 | 143.36 Million CNY | 89.53% |
| 2020 | 75.64 Million CNY | 59.03% |
| 2019 | 47.56 Million CNY | 35.94% |
| 2018 | 34.99 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 214.01 Million CNY | 0.0% |
| 2024 Q1 | 214.01 Million CNY | -13.92% |
| 2023 Q3 | 248.61 Million CNY | 2.99% |
| 2023 FY | 248.61 Million CNY | 45.12% |
| 2023 Q4 | 248.61 Million CNY | 0.0% |
| 2023 Q2 | 241.4 Million CNY | 0.0% |
| 2023 Q1 | 241.4 Million CNY | 40.91% |
| 2022 Q3 | 171.31 Million CNY | 10.18% |
| 2022 Q4 | 171.31 Million CNY | 0.0% |
| 2022 Q2 | 155.49 Million CNY | 0.0% |
| 2022 FY | 171.31 Million CNY | 19.49% |
| 2022 Q1 | 155.49 Million CNY | 8.46% |
| 2021 Q1 | 103.92 Million CNY | 37.38% |
| 2021 FY | 143.36 Million CNY | 89.53% |
| 2021 Q3 | 143.36 Million CNY | 37.96% |
| 2021 Q4 | 143.36 Million CNY | 0.0% |
| 2021 Q2 | 103.92 Million CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 Q3 | 75.64 Million CNY | 0.0% |
| 2020 FY | 75.64 Million CNY | 59.03% |
| 2020 Q4 | 75.64 Million CNY | 0.0% |
| 2019 FY | 47.56 Million CNY | 35.94% |
| 2018 FY | 34.99 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Wanjia Group Holdings Limited | 41.9 Million HKD | -493.266% |
| China Health Group Limited | 132.56 Million HKD | -87.544% |
| Tai United Holdings Limited | 3.52 Billion HKD | 92.944% |